معرفی
Peggy Chen is an Adjunct Lecturer at Monash University and at the Baker Department of Cardiovascular Research, Translation and Implementation, as well as an Honorary Fellow at the University of Melbourne. She serves as a Research Officer at Baker IDI Heart and Diabetes Institute in Melbourne, Australia since February 2020.
Dr. Chen earned her PhD in Biomedical Science from Monash University, establishing a strong foundation for her research career in cardiovascular medicine.
Her research focuses on cardiovascular pathophysiology, particularly examining the interplay between diabetes, insulin resistance, and heart disease. Dr. Chen's work extensively investigates coronary microvascular function, atrial fibrillation mechanisms, and novel therapeutic approaches for heart failure. Her laboratory utilizes sophisticated animal models including Goto-Kakizaki rats, mouse models of ischemic cardiomyopathy, and sheep models to study cardiovascular function and test potential treatments. Dr. Chen has made significant contributions to understanding how high-density lipoprotein (HDL) therapy can improve cardiac function post-myocardial infarction and how β-blockade can prevent vascular dysfunction in insulin-resistant states.
Analysis of Dr. Chen's publication record from 2015-2025 reveals a consistent focus on cardiovascular pathophysiology with particular emphasis on the intersection of metabolic disorders and heart disease. Her research spans molecular mechanisms, cellular processes, and whole-organ physiology, demonstrating a comprehensive approach to cardiovascular research. Key themes include coronary microvascular dysfunction in diabetic states, atrial remodeling in atrial fibrillation, and innovative gene therapy approaches for heart failure.
Dr. Chen has established collaborative research networks across multiple institutions in Australia, working closely with researchers at Baker IDI Heart and Diabetes Institute, Monash University, and the University of Melbourne. Her research program appears to be grant-funded, though specific grants are not mentioned in the provided information.
Her laboratory work involves advanced techniques including cardiovascular magnetic resonance imaging, molecular analysis of cardiac tissue, and sophisticated physiological measurements in various animal models. Dr. Chen's research team likely includes postdoctoral researchers, PhD students, and technical staff working on various aspects of cardiovascular pathophysiology and potential therapeutic interventions.
